Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$149K Sell
2,737
-464
-14% -$22.6K 0.04% 115
2026
Q1
$137K Sell
3,201
-48
-1% -$2.06K 0.04% 115
2025
Q4
$142K Buy
3,249
+2,632
+427% +$109K 0.04% 120
2025
Q3
$25.5K Sell
617
-385
-38% -$15.5K 0.01% 234
2025
Q2
$44.2K Buy
+1,002
New +$40K 0.01% 199

Other funds holding EXEL

Steph & Co's EXEL Position: Q2 2026 in Review

Steph & Co reduced its Exelixis (EXEL) stake by 14% in Q2 2026, selling an estimated $22.6K and leaving 2,737 shares worth $149K. The position accounts for 0.04% of the portfolio, ranked #115.

Steph & Co first reported a position in EXEL in Q2 2025 and has held it in 5 quarters since. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Steph & Co held 2,737 shares of Exelixis worth $149K as of Q2 2026.
  • Steph & Co sold 464 Exelixis shares in Q2 2026, an estimated $22.6K.
  • Exelixis made up 0.04% of Steph & Co's portfolio in Q2 2026, its #115 holding.
  • Steph & Co first reported a position in Exelixis in Q2 2025 and has held it in 5 quarters since.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Steph & Co's 13F filing for Q2 2026, filed 16 Jul 2026.